Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/03/21
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 02/14/17
End: 05/14/18
Due: 05/14/19
Phase: N/A
Priority: Normal
Start: 02/14/17
End: 05/03/18
Due: 05/03/19
Phase: N/A
Priority: Normal
Start: 06/02/17
End: 01/13/20
Due: 01/13/21
Phase: N/A
Priority: Normal
Start: 04/19/17
End: 08/23/18
Due: 08/23/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyme Disease Diagnostic Assay - Collection of Whole Blood | NCT05041595 | DiaSorin Inc. | user2@example.com | None | 2021-05-03 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects | NCT03060733 | DiaSorin Inc. | user2@example.com | None | 2017-02-14 | 2018-05-14 | 2019-05-14 | - | - | 2025-07-14 |
| Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects | NCT03060746 | DiaSorin Inc. | user2@example.com | None | 2017-02-14 | 2018-05-03 | 2019-05-03 | - | - | 2025-07-14 |
| EURECA (EUropeanRElapseCAlprotectin) Study | NCT05168917 | DiaSorin Inc. | user2@example.com | None | 2017-06-02 | 2020-01-13 | 2021-01-13 | - | - | 2025-07-14 |
| Fecal Calprotectin Collection Protocol | NCT03143517 | DiaSorin Inc. | user2@example.com | None | 2017-04-19 | 2018-08-23 | 2019-08-23 | - | - | 2025-07-14 |